NAGE
Niagen Bioscience, Inc. Common Stock
NAGE
NAGE
67 hedge funds and large institutions have $45.7M invested in Niagen Bioscience, Inc. Common Stock in 2024 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 20 increasing their positions, 11 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
67
Holders Change
+14
Holders Change %
+26.42%
% of All Funds
0.97%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.01%
New
20
Increased
20
Reduced
11
Closed
6
Calls
$513K
Puts
$259K
Net Calls
+$254K
Net Calls Change
+$185K
Top Buyers
| 1 |
Millennium Management
New York
|
+$1.6M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$881K |
| 3 |
Goldman Sachs
New York
|
+$669K |
| 4 |
Jane Street
New York
|
+$642K |
| 5 |
HF
HRT Financial
New York
|
+$411K |
Top Sellers
| 1 |
Citadel Advisors
Miami,
Florida
|
-$483K |
| 2 |
Renaissance Technologies
New York
|
-$298K |
| 3 |
BFM
Boothbay Fund Management
New York
|
-$213K |
| 4 |
Squarepoint
New York
|
-$88.5K |
| 5 |
Bank of New York Mellon
New York
|
-$54.4K |
